In contrast, triterpenoid-type compounds (e.g., GPM24, GPM30, GPM32) interacted with a separate subset of targets including ACE, AGTR2, VDR, and were more involved in cardiovascular and renin–angiotensin system-related pathways, as well as metabolic and viral disease modules. This evidence concerns the gene ACE and viral load.